BRIEF-Candel Therapeutics Presents Phase 3 Clinical Trial Of Can-2409

Reuters
Sep 29, 2025
BRIEF-Candel <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Presents Phase 3 Clinical Trial Of Can-2409

Sept 29 (Reuters) - Candel Therapeutics Inc CADL.O:

  • CANDEL THERAPEUTICS PRESENTS PHASE 3 CLINICAL TRIAL OF CAN-2409 IN LOCALIZED PROSTATE CANCER AT ASTRO 2025

Source text: ID:nGNX5Lvy86

Further company coverage: CADL.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10